Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography

被引:27
作者
Cheviron, N [1 ]
Rousseau-Plasse, A [1 ]
Lenfant, M [1 ]
Adeline, MT [1 ]
Potier, P [1 ]
Thierry, J [1 ]
机构
[1] Lab Chim Subst Nat, CNRS, F-91198 Gif Sur Yvette, France
关键词
angiotensin I-converting enzyme; ACE activity; acetyl-Ser-Asp-Lys-Pro; fluorescence; coumarin derivative; human plasma; HPLC;
D O I
10.1006/abio.2000.4484
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
N-Acetyl-Ser-Asp-Lys-Pro-OH (AcSDKP-OH), a negative regulator of hematopoietic stem cell proliferation, is shown to be a physiological substrate of angiotensin I-converting enzyme (ACE), a zinc-dipeptidyl carboxypeptidase, involved in cardiovascular homeostasis. Recently, a study carried out on captopril-treated volunteers revealed that the kinetics of [H-3]AcSDKP-OH hydrolysis in vitro in the plasma of donors correlates closely to the plasmatic ratio angiotensin II/angiotensin I, which characterized the conversion activity of ACE. This prompted us to design a fluorescent substrate, 2-[7-(dimethylamino)-2-oxo-2H-chromen-4-yl]acetyl-SDKP-OH, or coumarin-SDKP-OH, which could be an alternative to the radiolabeled analogue used in that study, allowing an easier and more rapid determination of enzyme activity. We report here the synthesis and the determination of the kinetics constants of this fluorescent derivative compared with those of [H-3]AcSDKP-OH with human plasma ACE (133 and 125 mu M, respectively), which are in the same range as those of the physiological substrate angiotensin I. Furthermore, the hydrolysis of the fluorescent substrate shows the same sensitivity toward chloride concentration as the natural substrate, demonstrating its specificity for N-domain hydrolysis. This fluorescent derivative was used to develop a sensitive assay for the determination of ACE activity in human plasma. (C) 2000 Academic Press.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 18 条
[1]   Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[2]   ANGIOTENSIN-CONVERTING ENZYME - CLINICAL-APPLICATIONS AND LABORATORY INVESTIGATIONS ON SERUM AND OTHER BIOLOGICAL-FLUIDS [J].
BENETEAUBURNAT, B ;
BAUDIN, B .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1991, 28 (5-6) :337-356
[3]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[4]  
Deddish PA, 1996, J PHARMACOL EXP THER, V279, P1582
[5]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND THE HEART [J].
GAVRAS, H .
HYPERTENSION, 1994, 23 (06) :813-818
[6]   METAL-COORDINATING SUBSTRATE-ANALOGS AS INHIBITORS OF METALLOENZYMES [J].
HOLMQUIST, B ;
VALLEE, BL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (12) :6216-6220
[7]  
JASPARD E, 1993, J BIOL CHEM, V268, P9496
[8]  
LAWTON G, 1992, ADV DRUG RES, V23, P161
[9]   INHIBITOR OF HEMATOPOIETIC PLURIPOTENT STEM-CELL PROLIFERATION - PURIFICATION AND DETERMINATION OF ITS STRUCTURE [J].
LENFANT, M ;
WDZIECZAKBAKALA, J ;
GUITTET, E ;
PROME, JC ;
SOTTY, D ;
FRINDEL, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :779-782
[10]   CHOOSING THE RIGHT ACE-INHIBITOR - A GUIDE TO SELECTION [J].
LEONETTI, G ;
CUSPIDI, C .
DRUGS, 1995, 49 (04) :516-535